COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 87 filers reported holding COHERUS BIOSCIENCES INC in Q2 2016. The put-call ratio across all filers is 2.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $396,758 | -5.8% | 106,085 | +7.5% | 0.00% | 0.0% |
| Q2 2023 | $421,376 | -24.9% | 98,683 | +20.3% | 0.00% | 0.0% |
| Q1 2023 | $561,188 | -15.4% | 82,045 | -2.0% | 0.00% | 0.0% |
| Q4 2022 | $663,150 | -16.3% | 83,731 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $792,000 | +29.2% | 82,384 | -2.7% | 0.00% | 0.0% |
| Q2 2022 | $613,000 | -41.3% | 84,695 | +4.6% | 0.00% | 0.0% |
| Q1 2022 | $1,045,000 | -25.0% | 80,958 | -7.2% | 0.00% | -50.0% |
| Q4 2021 | $1,393,000 | +3.2% | 87,281 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $1,350,000 | +10.2% | 84,028 | -5.1% | 0.00% | 0.0% |
| Q2 2021 | $1,225,000 | -5.5% | 88,550 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $1,296,000 | -16.2% | 88,707 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,546,000 | -43.4% | 88,975 | -40.2% | 0.00% | -50.0% |
| Q3 2020 | $2,730,000 | +75.1% | 148,853 | +70.5% | 0.00% | +33.3% |
| Q2 2020 | $1,559,000 | +1.7% | 87,299 | -7.6% | 0.00% | 0.0% |
| Q1 2020 | $1,533,000 | -10.9% | 94,508 | -1.1% | 0.00% | 0.0% |
| Q4 2019 | $1,721,000 | -11.9% | 95,575 | -0.9% | 0.00% | -25.0% |
| Q3 2019 | $1,954,000 | -7.2% | 96,449 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $2,106,000 | +92.9% | 95,297 | +19.0% | 0.00% | +100.0% |
| Q1 2019 | $1,092,000 | +47.4% | 80,061 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $741,000 | -43.4% | 81,860 | +3.1% | 0.00% | -33.3% |
| Q3 2018 | $1,310,000 | +30.6% | 79,416 | +10.8% | 0.00% | +50.0% |
| Q2 2018 | $1,003,000 | +50.4% | 71,646 | +18.8% | 0.00% | +100.0% |
| Q1 2018 | $667,000 | +25.4% | 60,327 | -0.2% | 0.00% | 0.0% |
| Q4 2017 | $532,000 | -36.3% | 60,465 | -3.3% | 0.00% | -50.0% |
| Q3 2017 | $835,000 | -14.4% | 62,553 | -7.9% | 0.00% | 0.0% |
| Q2 2017 | $975,000 | -30.6% | 67,940 | +2.3% | 0.00% | -33.3% |
| Q1 2017 | $1,405,000 | -18.0% | 66,440 | +9.2% | 0.00% | 0.0% |
| Q4 2016 | $1,713,000 | +2.5% | 60,840 | -2.6% | 0.00% | 0.0% |
| Q3 2016 | $1,672,000 | +60.2% | 62,440 | +1.0% | 0.00% | +50.0% |
| Q2 2016 | $1,044,000 | -1.5% | 61,840 | +23.8% | 0.00% | 0.0% |
| Q1 2016 | $1,060,000 | +5.8% | 49,938 | +14.4% | 0.00% | 0.0% |
| Q4 2015 | $1,002,000 | +16.4% | 43,658 | +1.6% | 0.00% | 0.0% |
| Q3 2015 | $861,000 | -30.8% | 42,969 | -0.2% | 0.00% | -33.3% |
| Q2 2015 | $1,245,000 | +228.5% | 43,069 | +247.3% | 0.00% | +200.0% |
| Q1 2015 | $379,000 | +83.1% | 12,400 | -2.4% | 0.00% | – |
| Q4 2014 | $207,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |